Breakthrough Discovery: Researchers Uncover Dysfunctional B Cells as a Novel Target for Cancer Immunotherapy
Researchers at the University of Pittsburgh, in collaboration with UPMC Hillman Cancer Center, have recently unveiled groundbreaking findings that shift ...
